Breaking News Instant updates and real-time market news.

FIT

Fitbit

$5.54

0.26 (4.92%)

, ADDYY

Adidas

$112.29

0.065 (0.06%)

09:03
02/27/18
02/27
09:03
02/27/18
09:03

Fitbit launches Fitbit Ionic: adidas edition smartwatch

Fitbit (FIT) launches Fitbit Ionic: adidas (ADDYY) edition, "a watch designed to help athletes of all levels improve their performance with running-specific training. The result of a partnership between Fitbit and adidas announced last year, Fitbit Ionic: adidas edition includes all the advanced health and fitness features of Fitbit Ionic plus provides a unique coaching experience through the adidas Train app, developed in collaboration with performance experts at adidas, that includes six on-screen workouts aimed at improving form, power and speed."

FIT

Fitbit

$5.54

0.26 (4.92%)

ADDYY

Adidas

$112.29

0.065 (0.06%)

  • 27

    Feb

FIT Fitbit
$5.54

0.26 (4.92%)

02/27/18
STFL
02/27/18
NO CHANGE
Target $5.5
STFL
Hold
Stifel keeps Hold on Fitbit, says expense management reassuring
Stifel analyst Jim Duffy said Fitbit's Q4 results and FY18 outlook were "directionally aligned" with his expectations, though he added that he is reassured by the company's expense management and inventory discipline. Duffy maintains a Hold rating and $5.50 price target on Fitbit, stating that he doesn't yet see a path to profitability and is "challenged to make a compelling upside case" for the stock.
02/27/18
SBSH
02/27/18
NO CHANGE
Target $4.5
SBSH
Sell
Fitbit price target lowered to $4.50 from $5 at Citi
Citi analyst Stanley Kovler lowered his price target for Fitbit to $4.50 citing the company's Q4 miss and guide down. The analyst maintains a Sell rating on the shares.
02/27/18
BOFA
02/27/18
NO CHANGE
Target $5
BOFA
Underperform
Fitbit price target lowered to $5,outlook disappoints, says BofA/Merrill
BofA/Merrill analyst Ryan Goodman said Fitbit's Q4 report and outlook fell short of expectations with its new flagship smartwatch, Iconic, experiencing weak sales as it faced competitive challenges. Goodman said the underwhelming reception of Iconic is a "worrisome sign" due to the importance of the launch and raises concerns as to Fitbit's ability to take market share. The analyst lowered his 2018 Fitbit revenue estimate to $1.5B from $1.78B and cut his price target to $5 from $6 given declining revenue, cash burn and product uncertainty, while maintaining and Underperform rating.
02/27/18
OPCO
02/27/18
NO CHANGE
Target $8
OPCO
Outperform
Fitbit transition starts 'modestly,' says Oppenheimer
Oppenheimer analyst Andrew Uerkwitz says Fitbit reported another "uninteresting" quarter. But with reactivations, cash being essentially flat, and recent digital health acquisitions, the analyst remains "ever the optimist." Uerkwitz reiterates an Outperform rating and $8 price target.
ADDYY Adidas
$112.29

0.065 (0.06%)

12/18/17
JEFF
12/18/17
NO CHANGE
JEFF
adidas still taking share from Nike in running, says Jefferies
Jefferies analyst Randal Konik says his updated webscrapes point to adidas (ADDYY) still gaining share from Nike (NKE) in running in three of the last four months across the U.S. and Europe. A survey of 200 footwear retailers indicate UltraBoost and NMD are the key drivers of share gains for adidas, Konik tells investors in a research note. He points out, however, that Nike's Air VaporMax is seeing traction. In basketball, Nike continues to dominate, while the recent launch of the Curry 4 is putting Under Armour (UAA) "back on the map," Konik writes.
12/22/17
OPCO
12/22/17
NO CHANGE
OPCO
Outperform
adidas valuation now lowest since late 2015, says Oppenheimer
Oppenheimer analyst Anna Andreeva says adidas (ADDYY) shares are down 15% since September while Nike (NKE) is up 21%. adidas' valuation is now the lowest since late 2015 and below Nike, Andreeva tells investors in a research note. She believes the company's growth trajectory has not changed and keeps an Outperform rating on the shares.
01/31/18
OPCO
01/31/18
UPGRADE
Target $70
OPCO
Outperform
Foot Locker upgraded to Outperform from Perform at Oppenheimer
Oppenheimer analyst Anna Andreeva upgraded Foot Locker (FL) to Outperform with a $70 price target. The shoe retailer closed yesterday down $1.38 to $49.90. With Nike's (NKE) "onset" of innovation and adidas' (ADDYY) ongoing momentum, Foot Locker is poised to stabilize as 2018 unfolds, Andreeva tells investors in a research note. The analyst notes the two brands account for 85% of Foot Locker's sales. Further, she views Foot Locker's valuation as inexpensive at current share levels. Channel checks also indicate that the retailer is making progress clearing through inventory overhang, Andreeva adds.
02/09/18
JEFF
02/09/18
NO CHANGE
JEFF
Buy
Under Armour discounting down dramatically in last three months, says Jefferies
Jefferies analyst Randal Konik says his firms' February webscrapes point to better traction at Under Armour (UAA) with discounts down in each of the last three months. The company's discounts decreased from 70% in November to 23% in February, down more than 30% year-over-year this month, Konik tells investors in a research note. Further, a survey of 200 footwear retailers shows the Under Armour HOVR Phantom is building momentum, the analyst adds. In addition, the survey shows Nike (NKE) is gaining back share from adidas (ADDYY) in running across the U.S. and Europe. In Basketball, Nike continues to dominate, while Under Armour's Curry 4 is resonating well with consumers, Konik writes. The analyst has a Buy rating on Under Armour and Hold rating on Nike.

TODAY'S FREE FLY STORIES

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
07/18/18
07/18
14:17
07/18/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADTN

Adtran

$16.20

0.15 (0.93%)

14:17
07/18/18
07/18
14:17
07/18/18
14:17
Downgrade
Adtran rating change  »

Adtran downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
07/18/18
07/18
14:16
07/18/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$280.80

0.38 (0.14%)

14:15
07/18/18
07/18
14:15
07/18/18
14:15
General news
Manufacturers in all Fed districts expressed concern about tariffs »

The Federal Reserve said…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$280.80

0.38 (0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PENN

Penn National

$35.05

-0.65 (-1.82%)

14:05
07/18/18
07/18
14:05
07/18/18
14:05
Options
Penn National call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$280.81

0.39 (0.14%)

14:02
07/18/18
07/18
14:02
07/18/18
14:02
General news
Employment continued to rise at 'modest to moderate pace,' Fed says »

The Federal Reserve said…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$280.81

0.39 (0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$280.81

0.39 (0.14%)

14:01
07/18/18
07/18
14:01
07/18/18
14:01
General news
Fed says economic activity continued to expand across the U.S. »

The Federal Reserve said…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$280.81

0.39 (0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,200.65

1.84 (0.15%)

, GOOGL

Alphabet Class A

$1,218.02

4.37 (0.36%)

14:00
07/18/18
07/18
14:00
07/18/18
14:00
Hot Stocks
Alphabet to take Q2 charge of $5.07B for European Commission fine »

Alphabet in a press…

GOOG

Alphabet

$1,200.65

1.84 (0.15%)

GOOGL

Alphabet Class A

$1,218.02

4.37 (0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 23

    Jul

  • 08

    Aug

  • 18

    Sep

  • 28

    Oct

13:55
07/18/18
07/18
13:55
07/18/18
13:55
Conference/Events
House Financial Services Committee to hold a hearing »

The Monetary Policy &…

GLW

Corning

$29.31

0.12 (0.41%)

13:54
07/18/18
07/18
13:54
07/18/18
13:54
Hot Stocks
Corning introduces Gorilla Glass 6, 'most durable cover glass to date' »

Corning introduced its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

TSLA

Tesla

$321.21

-1.58 (-0.49%)

13:50
07/18/18
07/18
13:50
07/18/18
13:50
Periodicals
Germany asks Tesla owners to pay back EUR 4000 incentive, electrek says »

Tesla's ongoing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

13:45
07/18/18
07/18
13:45
07/18/18
13:45
General news
Fed Chairman Powell's 2-day semi-annual testimony has concluded »

Fed Chairman…

13:45
07/18/18
07/18
13:45
07/18/18
13:45
General news
Breaking General news story  »

June Beige Book to be…

GM

General Motors

$39.90

-0.15 (-0.37%)

, FCAU

Fiat Chrysler

$19.37

-0.295 (-1.50%)

13:42
07/18/18
07/18
13:42
07/18/18
13:42
Periodicals
The U.S. auto industry aligned in push back on tariffs, WSJ says »

The U.S. auto complex,…

GM

General Motors

$39.90

-0.15 (-0.37%)

FCAU

Fiat Chrysler

$19.37

-0.295 (-1.50%)

DLPH

Delphi Technologies

$45.78

0.87 (1.94%)

BWA

BorgWarner

$46.47

0.8 (1.75%)

MGA

Magna

$61.62

1.03 (1.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 18

    Sep

HPQ

HP Inc.

$23.38

-0.22 (-0.93%)

13:40
07/18/18
07/18
13:40
07/18/18
13:40
Options
Short-term put buying in H-P »

Short-term put buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:30
07/18/18
07/18
13:30
07/18/18
13:30
General news
FX Action: USD-CAD »

FX Action: USD-CAD has…

13:25
07/18/18
07/18
13:25
07/18/18
13:25
General news
Treasury Action: yields rebounded from lows »

Treasury Action: yields…

AMGN

Amgen

$193.08

-0.85 (-0.44%)

13:25
07/18/18
07/18
13:25
07/18/18
13:25
Conference/Events
Brookings hosts a conversation with FDA Commisioner Gottlieb »

The USC-Brookings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 08

    Aug

GSK

GlaxoSmithKline

$41.00

-0.145 (-0.35%)

, PFE

Pfizer

$37.63

-0.04 (-0.11%)

13:23
07/18/18
07/18
13:23
07/18/18
13:23
Hot Stocks
GSK's ViiV to share data from landmark 2-drug regimen trials at AIDS 2018 »

ViiV Healthcare, the…

GSK

GlaxoSmithKline

$41.00

-0.145 (-0.35%)

PFE

Pfizer

$37.63

-0.04 (-0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 22

    Aug

  • 10

    Sep

RHT

Red Hat

$147.95

0.43 (0.29%)

13:20
07/18/18
07/18
13:20
07/18/18
13:20
Options
Notable position opened in RedHat »

Notable position opened…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
07/18/18
07/18
13:17
07/18/18
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
07/18/18
07/18
13:16
07/18/18
13:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GGP

GGP

$20.45

-0.25 (-1.21%)

13:15
07/18/18
07/18
13:15
07/18/18
13:15
Options
General Growth put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$80.55

1.83 (2.32%)

13:12
07/18/18
07/18
13:12
07/18/18
13:12
Periodicals
Novartis considering range of options for Sandoz generics unit, Bloomberg says »

Novartis is evaluating a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$80.56

1.84 (2.34%)

, TEVA

Teva

$23.46

0.32 (1.38%)

13:11
07/18/18
07/18
13:11
07/18/18
13:11
Recommendations
Novartis, Teva, Mylan, Pfizer, Amgen, Eli Lilly analyst commentary  »

Novartis report has…

NVS

Novartis

$80.56

1.84 (2.34%)

TEVA

Teva

$23.46

0.32 (1.38%)

MYL

Mylan

$36.02

-0.35 (-0.96%)

PFE

Pfizer

$37.61

-0.06 (-0.16%)

AMGN

Amgen

$193.01

-0.92 (-0.47%)

LLY

Eli Lilly

$90.07

0.5 (0.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 24

    Jul

  • 08

    Aug

  • 22

    Aug

  • 10

    Sep

  • 16

    Sep

  • 13

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.